Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Apr
19
2024
HRSA Aims for Swift Dispute Resolution with new 340B ADR Final Rule Polsinelli PC
Apr
19
2024
Money Trees (and Office Greens): Why Real Estate Developers are Transforming Vacant Office Spaces into Trendy Urban Farms ArentFox Schiff LLP
Apr
19
2024
HHS-OIG Highlights Anti-Fraud Safeguards for Patient Assistance Programs Backed Mainly By Drug Manufacturers Barnes & Thornburg LLP
Apr
18
2024
March 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Apr
18
2024
DOJ Just Said the Quiet Part Out Loud in Massachusetts Cannabis Case Bradley Arant Boult Cummings LLP
Apr
18
2024
Supreme Court Declines to Review FDA Labeling Preemption for State Claims Keller and Heckman LLP
Apr
18
2024
FDA Preemption of State Law for False Labeling Survives Appeal to Supreme Court Polsinelli PC
Apr
18
2024
Health-e Law Episode 8: What We Heard at HIMSS 2024 with Michael Orlando & Carolyn Metnick [Podcast] Sheppard, Mullin, Richter & Hampton LLP
Apr
17
2024
DOJ Files Second Qui Tam Lawsuit Against Regeneron Pharmaceuticals Tycko & Zavareei LLP
Apr
17
2024
Consolidated Appropriations Act of 2024 Protects Food Companies Against Lawsuits Targeting Healthy Claims Keller and Heckman LLP
Apr
17
2024
What to Know About New York’s New Supplement Law Going into Effect this Month Polsinelli PC
Apr
17
2024
Weight Loss, Miracle Medications & the Workplace Robinson & Cole LLP
Apr
17
2024
Top 10 Legal Issues in the Cannabis Industry in 2024 ArentFox Schiff LLP
Apr
16
2024
This Week in 340B: April 9 – April 15, 2024 McDermott Will & Emery
Apr
16
2024
Navigating Health Tech: Regulations for AI/ML in Medical Devices and Software [Video] Mintz
Apr
16
2024
BRight Minds in Healthcare Delivery Episode 5: Structuring and Maintaining Value-based Care Arrangements [Podcasts] Blank Rome LLP
Apr
16
2024
Environmental Developments to Watch in California in 2024 Beveridge & Diamond PC
Apr
16
2024
FDA Releases Data on EMA Honey Keller and Heckman LLP
Apr
15
2024
Preparing for Michigan Liquor License Renewal 2024-2025 Varnum LLP
Apr
15
2024
What Food & Beverage Companies Need to Know About the U.S. Consumer Product Safety Commission Foley & Lardner LLP
Apr
15
2024
U.S. Environmental Protection Agency Finalizes National Primary Drinking Water Regulations for Certain PFAS Chemicals Babst, Calland, Clements & Zomnir, P.C.
Apr
15
2024
A Win for the SEC on Shadow Trading. Now What? ArentFox Schiff LLP
Apr
15
2024
Preparing for Evolving Cybersecurity Threats McDermott Will & Emery
Apr
15
2024
No Can Do for Mo Cann Do: Missouri Supreme Court Upholds Denial of Cannabis License to Applicant with Insufficient Paperwork Bradley Arant Boult Cummings LLP
Apr
15
2024
Chlormequat Contamination in Food Products Draws Attention K&L Gates
Apr
12
2024
ARS Researchers Discover Ability of Cotton Gin Waste to Transform Silver Ions into Silver Nanoparticles Bergeson & Campbell, P.C.
Apr
12
2024
McDermottPlus Check-Up: April 12, 2024 McDermott Will & Emery
Apr
12
2024
340B Remedy Rule and Medicare Advantage Rates: Navigating Shifting Payments McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins